Literature DB >> 10542137

Development of human and rabbit vaginal smooth muscle cell cultures: effects of vasoactive agents on intracellular levels of cyclic nucleotides.

A Traish1, R B Moreland, Y H Huang, N N Kim, J Berman, I Goldstein.   

Abstract

In this study, we subcultured and characterized human and rabbit vaginal smooth muscle cells and investigated the synthesis of second messenger cyclic nucleotides in response to vasodilators and determined the activity and kinetics of phosphodiesterase (PDE) type 5 (EC 3.1.4.35 3',5'-cyclic GMP phosphodiesterase). Cultured vaginal cells exhibited growth characteristics typical of smooth muscle cells and immunostained with antibodies against alpha smooth muscle actin. The cells retained functional prostaglandin E and beta-adrenergic receptors as demonstrated by increased intracellular cAMP synthesis in response to PGE1, or isoproterenol. The response to these vasoactive substances was augmented with forskolin, suggesting stabilization of G-protein-activated adenylyl cyclases. Treatment with the nitric oxide donor, sodium nitroprusside, in the presence of sildenafil, a PDE type 5 inhibitor, enhanced intracellular cGMP synthesis and accumulation. Incubation of rabbit vaginal tissue with sildenafil, sodium nitroprusside, and PGE1 or forskolin produced a marked increase in intracellular cGMP. These observations were similar to findings with cultured cells and suggest that subcultured cells retain functional characteristics exhibited in intact tissue. The cells retained phosphodiesterase type 5 expression as shown by specific cGMP hydrolytic activity. Sildenafil and zaprinast inhibited cGMP hydrolysis competitively and bound with high affinity (Ki = 7 and 250 nM, respectively). These observations suggest that cultured human and rabbit vaginal smooth muscle cells retained their metabolic functional integrity and this experimental system should prove useful in investigating the pathway of nitric oxide and PDE type 5 inhibitors in modulating vaginal smooth muscle tone.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10542137     DOI: 10.1006/mcbr.1999.0164

Source DB:  PubMed          Journal:  Mol Cell Biol Res Commun        ISSN: 1522-4724


  5 in total

1.  In vitro functional responses of isolated human vaginal tissue to selective phosphodiesterase inhibitors.

Authors:  Stefan Uckert; Vicky Ehlers; Vivian Nüser; Matthias Oelke; Wolfgang Kauffels; Friedemann Scheller; Udo Jonas
Journal:  World J Urol       Date:  2005-11-05       Impact factor: 4.226

Review 2.  Phosphodiesterase inhibitors in female sexual dysfunction.

Authors:  Margit Mayer; Christian G Stief; Michael C Truss; Stefan Uckert
Journal:  World J Urol       Date:  2005-10-25       Impact factor: 4.226

3.  UK-414,495, a selective inhibitor of neutral endopeptidase, potentiates pelvic nerve-stimulated increases in female genital blood flow in the anaesthetized rabbit.

Authors:  C P Wayman; D Baxter; L Turner; P H Van Der Graaf; A M Naylor
Journal:  Br J Pharmacol       Date:  2010-05       Impact factor: 8.739

Review 4.  Endothelial nitric oxide synthase regulation in female genital tract structures.

Authors:  Biljana Musicki; Tongyun Liu; Gwen A Lagoda; Trinity J Bivalacqua; Travis D Strong; Arthur L Burnett
Journal:  J Sex Med       Date:  2008-12-05       Impact factor: 3.802

5.  Sildenafil citrate in the treatment of pain in primary dysmenorrhea: a randomized controlled trial.

Authors:  R Dmitrovic; A R Kunselman; R S Legro
Journal:  Hum Reprod       Date:  2013-08-06       Impact factor: 6.918

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.